{"id":1569187,"date":"2024-01-03T11:35:42","date_gmt":"2024-01-03T08:35:42","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=1569187"},"modified":"2024-01-03T11:35:42","modified_gmt":"2024-01-03T08:35:42","slug":"oms-scapa-porumbelul-tehnologia-vaccinului-arn-mesager-a-dat-rateuri","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=1569187","title":{"rendered":"OMS scap\u0103 porumbelul. Tehnologia vaccinului ARN mesager a dat rateuri"},"content":{"rendered":"<div class=\"articleBody\" data-key=\"articleBody\">&lt;div&gt;&lt;span style=&#8221;font-weight: bold;&#8221;&gt;Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii (OMS) cere extinderea utiliz\u0103rii tehnologiei ARN mesager pentru tratarea mai multor boli transmisibile \u0219i netransmisibile. \u00cen acela\u0219i timp, organiza\u021bia cere \u00eens\u0103 vaccinuri mai stabile la temperatur\u0103, o durat\u0103 de protec\u021bie mai mare \u0219i o eficacitate \u00eempotriva unei game variate de tulpini \u0219i variante. Pe de alt\u0103 parte, OMS a subliniat importan\u021ba construirii \u00eencrederii \u00een tehnologiile ARN mesager, pentru a \u00eembun\u0103t\u0103\u021bi absorb\u021bia actual\u0103 \u0219i viitoare a vaccinurilor.&lt;\/span&gt;&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;De\u0219i vorbe\u0219te despre succesul vaccinului Covid bazat pe tehnologia ARN mesager, OMS admite limit\u0103rile acestui produs, solicit\u00e2nd continuarea cercet\u0103rilor pentru dezvoltarea unor vaccinuri mai stabile la temperatur\u0103, cu o durat\u0103 mai mare de protec\u021bie \u0219i care s\u0103 asigure eficacitatea \u00eempotriva unei game variate de tulpini \u0219i variante.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;Consiliul \u0218tiin\u021bific al Organiza\u021biei Mondiale a S\u0103n\u0103t\u0103\u021bii (OMS) a publicat un raport care analizeaz\u0103 beneficiile poten\u021biale \u0219i limit\u0103rile tehnologiei vaccinului ARNm, realizate dup\u0103 decenii de investi\u021bii \u00een \u0219tiin\u021ba de baz\u0103 care exploreaz\u0103 modific\u0103rile chimice \u0219i r\u0103spunsurile imune la ARN, cu poten\u021bialele lor aplica\u021bii pentru HIV, virusul respirator sinci\u021bial (RSV), sindromul respirator acut sever (SARS), \u0219i terapii \u0219i vaccinuri \u00eempotriva cancerului.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;\u201dBeneficiile vaccinurilor ARNm Covid-19 nu au fost distribuite \u00een mod egal la nivel global, cu o capacitate de cercetare \u0219i dezvoltare insuficient\u0103, bariere de proprietate intelectual\u0103 \u0219i cerin\u021be de lan\u021b ultra-reg, precum \u0219i costuri ridicate pentru \u021b\u0103rile cu venituri mici \u0219i medii. Deblocarea poten\u021bialului tehnologiei ARNm dincolo de vaccinurile Covid-19 va necesita cercet\u0103ri solide pentru a aborda limit\u0103rile directe\u201d, a declarat profesorul Harold Varmus, pre\u0219edinte al Consiliului \u0218tiin\u021bific al OMS, fost director al Institutului Na\u021bional de S\u0103n\u0103tate din SUA. Raportul recomand\u0103 un cadru pentru a evalua valoarea tehnologiei ARNm \u00een dezvoltarea vaccinurilor \u0219i a medicamentelor \u00eempotriva altor boli infec\u021bioase, care ar putea ajuta, de asemenea, la stabilirea rolului poten\u021bial al tehnologiei \u00een abordarea cancerului \u0219i a bolilor autoimune.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt; &lt;div&gt;&lt;span class=&#8221;subtitlu&#8221;&gt;Se preg\u0103tesc noi vaccinuri&lt;\/span&gt;&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;Potrivit raportului OMS, \u00een prezent se desf\u0103\u0219oar\u0103 studii clinice de faz\u0103 3 pentru vaccinuri ARNm \u00eempotriva citomegalovirusului (un virus comun care poate amenin\u021ba bebelu\u0219ii \u0219i cei cu un sistem imunitar sl\u0103bit), gripa A \u0219i B, \u0219i RSV. Exist\u0103, de asemenea, cercet\u0103ri \u00een desf\u0103\u0219urare pentru vaccinuri cu aceast\u0103 tehnologie pentru tuberculoz\u0103, malarie, HIV, precum \u0219i \u00een bolile netransmisibile. Raportul solicit\u0103, de asemenea, cercet\u0103ri suplimentare pentru a aborda poten\u021bialul acestei tehnologii, precum \u0219i limit\u0103rile acesteia.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;\u201d\u00cembun\u0103t\u0103\u021birea stabilit\u0103\u021bii vaccinurilor ARNm la temperaturi mai ridicate ar trebui s\u0103 fie o \u021bint\u0103 cheie a eforturilor de investi\u021bii \u0219i de cercetare. O alt\u0103 recomandare cheie este asigurarea dezvolt\u0103rii \u0219i accesului prin investi\u021bii \u0219i aplicarea lec\u021biilor din ini\u021biativele Covid-19, cum ar fi ACT-Accelerator, care a lucrat pentru a asigura accesul la teste, tratamente \u0219i vaccinuri Covid-19.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;\u201ePentru a maximiza impactul tehnologiilor ARNm, este vital s\u0103 promov\u0103m \u0219i s\u0103 consolid\u0103m cercetarea, merg\u00e2nd \u021bar\u0103 cu \u021bar\u0103, astfel \u00eenc\u00e2t fiecare regiune s\u0103 aib\u0103 un ecosistem \u0219tiin\u021bific, de cercetare \u0219i dezvoltare dinamic \u0219i sus\u021binut\u201d, a spus dr. Jeremy Farrar, \u0219eful oamenilor de \u0219tiin\u021b\u0103 din OMS.&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;&lt;span class=&#8221;subtitlu&#8221;&gt;Ezitarea \u0219i ne\u00eencrederea trebuie anihilate&lt;\/span&gt;&lt;\/div&gt; &lt;div&gt;&lt;br \/&gt; &lt;\/div&gt; &lt;div&gt;Reprezentan\u021bii OMS au mai cerut investi\u021bii \u0219i un angajament pentru un acces echitabil, un ecosistem global de cercetare mai divers, care vor aborda mai bine bolile transmisibile \u0219i netransmisibile \u0219i vor \u00eembun\u0103t\u0103\u021bi rezultatele s\u0103n\u0103t\u0103\u021bii cu noi vaccinuri mARN sigure \u0219i eficiente \u0219i poten\u021bial terapeutice pentru to\u021bi. Totodat\u0103, raportul a eviden\u021biat importan\u021ba construirii \u00eencrederii \u0219i a \u00eembun\u0103t\u0103\u021birii comunic\u0103rii \u00een jurul tehnologiilor ARNm, pentru a limita ezitarea \u0219i dezinformarea \u0219i pentru a \u00eembun\u0103t\u0103\u021bi absorb\u021bia actual\u0103 \u0219i viitoare a vaccinurilor.&lt;\/div&gt; &lt;div&gt;&nbsp;&lt;\/div&gt; &lt;div&gt;&lt;span style=&#8221;font-weight: bold;&#8221;&gt;Parteneriat &lt;a href=&#8221;http:\/\/www.national.ro\/coronavirus\/oms-scapa-porumbelul-tehnologia-vaccinului-arn-mesager-a-dat-rateuri-809534.html&#8221; target=&#8221;_blank&#8221; style=&#8221;color: rgb(239, 0, 27);&#8221;&gt;Na\u021bional&lt;\/a&gt;&lt;\/span&gt;&lt;\/div&gt;&lt;\/div&gt;<\/div>\n<p> Source URL: https:\/\/www.activenews.ro\/stiri\/OMS-scapa-porumbelul.-Tehnologia-vaccinului-ARN-mesager-a-dat-rateuri-186613<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&lt;div&gt;&lt;span style=&#8221;font-weight: bold;&#8221;&gt;Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii (OMS) cere extinderea utiliz\u0103rii tehnologiei ARN mesager pentru tratarea mai multor boli transmisibile \u0219i netransmisibile. \u00cen acela\u0219i timp, organiza\u021bia cere \u00eens\u0103 vaccinuri mai stabile la temperatur\u0103, o durat\u0103 de protec\u021bie mai mare \u0219i o eficacitate \u00eempotriva unei game variate de tulpini \u0219i variante. Pe de alt\u0103 parte, OMS a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1569193,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[98],"class_list":["post-1569187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-romania","tag-activenews-ro"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/1569187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1569187"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/1569187\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/media\/1569193"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1569187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1569187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1569187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}